TRIM24 and esophageal squamous cell carcinoma: Moreover, patients with low expression have more postoperative relapse and metastasis than those with high expression (72.4% [97/134] vs 27.6% [37/134], P=0.001, Table 1), implying that TRIM24 may suppress ESCC development and metastasis.